Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial

Article

Abstract: Background: Levoketoconazole is a ketoconazole stereoisomer in development for treatment of Cushing'

Palabras claves:

Autores:

Biller B.M.K., Cohen F., Elenkova A., Feelders R.A., Fleseriu M., Geer E.B., Greenman Y., Pivonello R., Richard J. Auchus, Salvatori R., Witek P.

Fuentes:

scopus